Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes

INTRODUCTION The aim of the study was to investigate predictors of mortality in patients hospitalized with hyperkalemia. MATERIAL AND METHODS Data among hospitalized patients with hyperkalemia (serum potassium ≥ 5.1 mEq/l) were collected. Patients with end-stage renal disease on dialysis were excluded. RESULTS Of 15,608 hospitalizations, 451 (2.9%) episodes of hyperkalemia occurred in 408 p...

The association between drospirenone and hyperkalemia: a comparative-safety study

BACKGROUND Drospirenone/ethinyl-estradiol is an oral contraceptive (OC) that possesses unique antimineralocorticoid activity. It is conjectured that drospirenone, taken alone or concomitantly with spironolactone, may be associated with an increased risk of hyperkalemia. METHODS A retrospective cohort study was conducted evaluating women between 18-46 years of age in the Lifelink™ Health Plan ...

MANAGEMENT OF SEVERE HYPERKALEMIA

Hypokalemia and Hyperkalemia

A complete Works Cited list begins on page 15. Mention of commercial products does not indicate endorsement. Faculty Carol Whelan, APRN, has been working in nursing education since 2000. She received her Master’s degree in psychiatric/mental health nursing from St. Joseph College in West Hartford, Connecticut, and completed post-graduate nurse practitioner training at Yale University. Ms. Whela...

Editorial Hyperkalemia in Predialysis Patients

Potassium homeostasis is generally well maintained in patients with advanced CKD until the GFR falls below 10–15 ml/min. Loss of nephron mass is counterbalanced by an adaptive increase in the secretory rate of K1 in remaining nephrons, such that fractional excretion of K1 is increased. In a study of normokalemic patients with stage 4 CKD, the fractional excretion of K1 was 126% compared with 26...